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Accumulation of Radioiodinated 15-(p-Iodophenyl)-6-
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Coronary Occlusion and Reperfusion
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MIAORONG ZHENG, MD,* DONALD HNATOWICH, PHD,* MARK M. GOODMAN, PHD,t
FURN F. KNAPP, PHDt
Worcester. Massachusetts and Oak Ridge. Tennessee
The myocardial uptake of IS-(p-iodophenyl)-6-tellura-
pentadecanoic acid (TPDA) was studied in dogs during
coronary occlusion and after reperfusion. In eight dogs
with a 3 hour occlusion (Group A) with (n = S) and
without (n = 3) 30 minutes of reperfusion, iodine-l2S
TPDA uptake correlated well with microsphere myo-
cardial blood Dow over a wide range of Dow levels (n =
111, r = 0.94). In six dogs with a 20 minute occlusion
of the left anterior descending coronary artery and 1
hour ofreperfusion (Group B), iodine-l2S TPDA uptake
correlated equally well with myocardial blood Dow (n =
37, r = 0.90). There was no difference between the
slopes of regression lines tor Groups A and B, indicating
no release from the myocardiumof radloiodlnatedTPDA.
Dual radiolabeling of TPDA was employed in five Group
A animals by intravenous injection of iodine-l2S TPDA
Interest in the use of radioiodinated fatty acids for myo-
cardial imaging is derived from three observations: I) ra-
diolabcling with iodine-123 provides a gamma-emitting
radionuclide with desirable detection and imaging qualities,
2) radioiodinated fatty acids may be employed to assess
regional fatty acid metaboli sm , and 3) radioiodinated fatty
acids concentrate in the myocardium in proportion to re-
gional blood flow (l). These features of radioiodinated fatty
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during coronary occlusion and iodine-BI TPDA after
reperfusion. In 63 myocardial samples, microsphere re-
perfusion flow and iodine-131 TPDA uptake were closely
correlated (r = 0.91). As with monovalent cations, at
myocardial flows higher than control flows, iodine-BI
TPDA uptake was Dow-limited.
It is concluded that: 1) radioiodinated TPDA accu-
rately reveals severely ischemic areas of myocardium
without myocardial release of the radionuclide in coro-
nary occlusions lasting 20 to 180 minutes and followed
by reperfusion, and 2) double radiolabeled TPDA allows
assessmentof both occlusionand reperfusion flows. This
compound may find an application in the measurement
of infarct size and the evaluation of interventional ther-
apies in acute myocardial infarction.
acids have been the basis for several clinical investigations
(2-8) involving patients with coronary artery disease and
cardiomyopathy.
An attractive radiolabeled fatty acid for the evaluation
of regional myocardial blood flow would be one that reache s
a rapid regional distribution after intravenous administration
and would show minimal redistribution (redistribution is
defined as the release of a radiotracer from the myocardium
after its initial extraction) over time . Such an agent, there-
fore, would be "trapped" and its use would be similar to
the use of radioactive miscrospheres to measure regional
flow. The availability of an agent that could be administered
intravenously would be an attractive alternative to the in-
vasive intracoronary injection of radio labeled microspheres.
Recently , Goodman and Knapp and their coworkers (9-
II) reported 15-Cp-iodophenyl)-6-tellurapentadecanoic acid
(TPDA) as a new radioiodinated fatty acid with interesting
biologic properties. The tellurium heteroatom in the fatty
acid chain of radioiodinated TPDA appears to inhibit free
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fatty acid metabolism, presumably by interfering with beta
oxidation. This results in prolonged "trapping" of the mod-
ified fatty acid molecule in the myocardium. Indeed, after
rapid myocardial cell uptake, radioiodinated TPDA exhibits
prolonged myocardial retention, minimal deiodination and
high heart to blood ratios in rats (9). If the myocardial
distribution of radioiodinated TPDA does change little after
intravenous administration, it has great potential as an im-
aging agent for patients with acute myocardial infarction.
The purposes of this investigation were to: I) study the
relation between radio iodinated TPDA uptake by the heart
and regional myocardial blood flow as measured by micro-
spheres in acutely ischemic myocardial regions, 2) deter-
mine if the correlation between radioiodinated TPDA uptake
and microsphere flow persists over time and after reperfu-
sion, and 3) evaluate the feasibility of serial injections of
radio iodinated TPDA as a dual tracer technique for assessing
interventions aimed at myocardial infarct size reduction.
Methods
Experimental models. Eighteen dogs of either sex
weighing 18 to 33 kg were anesthetized with sodium pen-
tobarbital, 35 mg/kg body weight, intravenously. The tra-
chea was intubated and respiration maintained by a Harvard
respirator pump. The femoral artery and vein were cannu-
lated for measurement of arterial pressure and fluid admin-
istration, respectively. A left lateral thoracotomy was per-
formed and the exposed heart was suspended in a pericardial
cradle. The left atrium was cannulated for administration
of radioisotopic microspheres and monitoring left atrial pres-
sure The left anterior descending coronary artery was dis-
sected free below its first diagonal branch. In an attempt to
produce greater degrees of ischemia, the occlusion clamp
was placed above the first diagonal branch in Group B
animals (see later). Left anterior descending coronary artery
occlusions were performed using an atraumatic vascular
clamp. All 18 dogs received an injection of lidocaine (Xy-
locaine, Astra Laboratories), 100 mg intravenously over a
1 minute interval. This dose was administered three more
times during the first hour after occlusion, and then twice
hourly. Four dogs had irreversible ventricular fibrillation
after coronary artery occlusion and were excluded from the
study. Animals used in this study were maintained and used
in accordance with recommendations in the Guide for the
Care and Use ofLaboratory Animals, prepared by the ILAR,
NRC (DHEW Publication No. NIH 78-23, 1978) and guide-
lines of the Animal Care Advisory Committee of the Uni-
versity of Massachusetts Medical School.
Experimental protocel. Two experimental groups were
used: I) Group A: eight dogs with a 3 hour occlusion of
the left anterior descending coronary artery with and with-
out reperfusion (Fig. 1, top). In all eight dogs, the left
anterior descending coronary artery was occluded and 5
minutes later iodine-125 TPDA, approximately 25 to 40
/LCi. was given intravenously. Immediately after the TPDA
injection, radioactive microspheres (chromium-51 or cobalt-
57, 4 X 106 spheres) were injected into the left atrium. The
coronary occlusion was maintained for 3 hours. At the end
of 3 hours, three of the eight dogs were sacrificed. In the
remaining five dogs, the occlusion clamp was removed and
reperfusion was allowed for 30 minutes (two dogs) or 60
minutes (three dogs). At the end of this time, an injection
of iodine-131 TPDA (approximately 200 /LCi) was given
intravenously and ruthenium-103 microspheres, 4 X 106
spheres, were administered into the left atrium. The dogs
were sacrificed immediately after the final injections. 2)
Group B: six dogs with a 20 minute occlusion of the left
anterior descending coronary artery and 1 hour of reper-
fusion (Fig. 1, bottom). Iodine-125 TPDA (intravenously)
@OUP B)
Figure 1. Experimental groups. Top panel, Grc
A. Bottom panel, Group B. Co-57 = cobalt-.
Cr-51 = chronium-51. I. V. = intravenous; L
= left anterior descending coronary artery; TPI
= 15-(p-iodophenyl)-6-tellurapentadecanoic aci
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and cobalt-57 microspheres were injected into the left atrium
5 minutes after coronary occlusion. After I hour of reper-
fusion, iodine-131 TPDA (intravenously) and ruthenium-
103 microspheres were injected into the left atrium, fol-
lowed by immediate sacrifice. In Group B, all microsphere
doses consisted of 4 x 106 spheres. All animals were sac-
rificed by intravenous potassium chloride solution.
Radioiodinated fatty acids. Both iodine-125 and io-
dine-131-labeled 15-(p-iodophenyl)-6-tellurapentadecanoic
acid (TPDA) were prepared as described earlier (9-11). P-
(iodophenyl)nonyl chloride was radiolabeled with iodine-
125 (3.89 mCi; specific activity, 600 mCi/mmol) and iodine-
131 (5.1 mCi; specific activity, 1,000 mCi/mmol). The ra-
dioiodinated p-(iodephenyl)nonyl chloride substrates were
prepared by radioiodide decomposition of the corresponding
piperidyltriazene substrates and coupled with sodium (meth-
ylvaleryl) tellurol to produce radioiodinated methyl 15-(p-
[I]iodophenyl-6-tellurapentadecanoic acid). The methyl es-
ters were purified by absorption column chromatography
and converted to the corresponding free acids by refluxing
under argon in ethanol and I N sodium hydroxide to yield
859 /LCi of 15-(p-[ I 25I]iodophenyl-6-tellurapentadecanoic
acid and 2.9 mCi 15-p-[1311]-iodophenyl-6-tellurapentade-
canoic acid. Each showed a single radioactive component
R, (0.50) on thin layer chromatography (4% methyl alcohol
and chloroform). The radioactive fatty acids were stored
under argon in amber-colored break-seal tubes; the tubes
were opened immediately before formulation and used to
minimize any oxidation decomposition. Only minimal de-
composition has been detected with samples stored for sev-
eral weeks.
Tissue sampling and in vitro counting. Each left ven-
tricle was sectioned into 1 em slices below the level of the
site of left anterior descending coronary occlusion. The planes
of section extended from the level of the occlusion to the
apex of the left ventricle. The apical plane was discarded
because the left anterior descending coronary artery con-
tributes disproportionately to this slice. From each slice,
samples were taken from the center of the left ventricular
anterior wall (between the interventricular septum and the
anterior papillary muscle). Reference samples of the normal
posterior wall (180 0 from the region of left anterior de-
scending coronary artery) were likewise taken from each
slice. Each sample and reference was divided in half into
an epicardial and endocardial sample (Fig. 2). The mean
sample weight ± standard deviation was 0.50 ± 0.23 g.
The mean number of anterior left ventricular samples per
dog was 8 to 10 (with an equal number of reference sam-
ples). The sampling technique follows the procedure de-
scribed by Chu et al. (12).
Relative myocardial blood flows were investigated using
tracer micro spheres (New England Nuclear Corp.). Micro-
spheres (± standard deviation) were 9 ± 2 /Lm in diameter.
After 10 to 15 minutes of firm agitation with a vortex mixer,
f
Sampled
LAD · dependent
anterior LV wall
Figure 2. Identification of ischemic areas.Transverse midventric-
ular section. The ischemic anterior wall is that portion located
between septum and anterior papillary muscle. APM = anterior
papillary muscle; ENDO = endocardium; EPI = epicardium;
LAD = left anteriordescending coronary artery; LV = left ven-
tricle; PPM = posterior papillary muscle.
the microspheres were administered via the left atrium. The
described mixing prevented microsphere aggregation as as-
sessed by light microscopic examination. The employed
microspheres were radiolabeled with chromium-51, cobalt-
57, or ruthenium-l03.
Samples were assayed for radioiodine content (iodine-
125, iodine-l31) and microsphere activities (chromium-51,
cobalt-57, ruthenium-l03) using a multichannel analyzer
(Canberra Instruments, model 8100). In all instances,
Compton spillover of counts from the higher to the lower
energy isotopes was computed and corrected as recom-
mended by Heyman et al. (13). Although iodine-131 emits
beta radiation, the gamma radiations from the decay of
xenon-131m are the major (82%, 364 keY) emissions de-
tected by gamma-well counting. For technical reasons in
the preparation of iodine-I 3 I TPDA, we had to administer
a five-fold higher specific activity of iodine-13l. This was
not corrected after counting. However, the lack of difference
between the slopes of the animals in Group A who did or
did not undergo reperfusion (see later) lends credence to the
results obtained when using iodine-125 and iodine-13l to-
gether. All values were expressed as the ratio of counts/min
per g heart muscle in the ischemic anterior wall tissue to
counts/min per g myocardium in the nonischemic circumflex
coronary artery distribution (Fig. 2). This is relative coro-
nary artery flow. Microsphere loss was not a consideration
in our experiments because Murdock and Cobb (14) have
shown that there is no evidence for loss of microspheres
during the first 6 hours after coronary artery occlusion.
Statistical analysis. All values are expressed as mean
± standard deviation. Linear regression analyses were per-
formed using standard formulas. Statistical differences among
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variates and slopes of lines were assessed using the Student 's
paired and nonpaired t tests (15),
Results
Group A (3 hours of occlusion)
Hemodynamic changes. When iodine- l2 5 TPDA was
given intravenously , no effect on heart rate , blood pressure
or left atrial pressure was observed immediately or at 3 hours
of occlusion of the left anterior descending coronary artery
(Table I). Control left atrial pressure was 4 ± I mm Hg
and did not change during the period of observation. These
data do not demonstrate a lack of hemodynamic effects of
TPDA , because in those dogs (Group B) given iodine-l25
and iodine-131 TPDA, a slight decrease in systolic blood
pressure after occlusion and reperfusion was noted.
Relation between iodine-l2S TPDA myocardial up-
take and regional myocardial blood flow in 3 hour coro-
nary occlusion. Figure 3 demonstrates that in 3 hour coro-
nary occlusion, a close relation existed between iodine-125
TPDA uptake and microsphere myocardial blood flow over
a wide range of endocardial and epicardial ischemic regional
myocardial flows. There was no difference between the
slopes of the regression lines of the three dogs in Group A
without reperfusion and those of the five dogs with reper-
fusion for 30 (two dogs) or 60 (three dogs) minutes (prob-
ability [p] > 0 .05, t test for differences between slopes
calculated by the method employed in reference 15). There-
fore, because there were no intergroup differences, the III
data points plotted in Figure 3 are the data from all dogs in
Group A.
As demonstrated, in the flow range thought to be asso-
ciated with severe myocardial ischemia, that is, when there
was greater than 50% myocardial flow reduction (16), io-
dine-125 TPDA uptake was equally reduced (square out-
lined 'Jy dashed line in Fig. 3), although TPDA consistently
tended to underestimate the severity of myocardial blood
reduction. The slope and y intercept of the iodine-I 25 TPDA
versus flow relation does not appear to be different from
that reported for thallium-20 I (17 ,18) before redistribution
ofthallium-201 has occurred. There was some scatter in the
iodine-125 TPDA uptake ratios corresponding to flow ratios
between 40 and 70% of control values.
Relation between iodine-131 TPDA myocardial up-
take and regional myocardial blood flow after reperfu-
sion in dogs undergoing 3 hours of occlusion. Figure 4
demonstrates that there was an excellent correlation between
iodine-131 TPDA uptake and myocardial arterial flow in
animals undergoing 3 hours of coronary occlusion and either
30 (two dogs) or 60 minutes (three dogs) of reperfusion.
However, at all myocardial blood flows, iodine-131 TPDA
uptake was uniformly lower than microsphere myocardial
flow. At flows greater than unity, the results are consistent
with the known passive diffusion limitation for tracers that
accumulate in the myocardium (19,20) .
Group B (20 minutes of occlusion and I hour of
reperfusion )
Hemodynamic changes. When either iodine-125 TPDA
or iodine-I 3 I TPDA was given intravenously under contin-
uous monitoring , no effects on heart rate or left atrial pres-
sure were noted . Table I shows that the only noticeable
effect of combined coronary occlusion and iodine-125 and
iodine-131 TPDA injections at the end of the reperfusion
period (relative to control measurements) was a small de-
crease in systolic blood pressure . Thus, a lack of hemo-
dynamic effect of TPDA was not demonstrated. In Group
B, control left atrial pressure was 5 ± I mm Hg throughout
the experiment.
Relation between iodine-l2S TPDA myocardial up-
take and regional myocardial blood flow in 20 minute
coronary occlusion. Figure 5 demonstrates that there was
Table 1. Heart Rate and Blood Pressure Data in 14 Dogs
Group A (8 dogs)
Heart rate (beats/min)
Systolic blood pressure (rnrn Hg)
Diastolic blood pressure (rnrn Hg)
Control Period
137 ± 35
108 ± 17
84 ± 20
After 3 Hours of
Occlusion
139 ± 24
114 ± 16
89 ± 14
p Value
NS
NS
NS
Group B (6 dogs)
Heart rate (beats/min)
Systolic blood pressure (rnm Hg)
Diastolic blood pressure (mm Hg)
Control Period
159 ± 30
139 ± 24
98 ± 17
After 20 Minutes of
Occlusion and 1
Hour Reperfusion
160 ± 33
123 ± 19
85 ± 17
p Value
NS
*
NS
*p < 0.05 . NS = not significant; p = probability.
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Figure 3. Group A. Relation between iodine-125 TPDA
uptakeand regional microsphere myocardial bloodflow
in 3 hours of occlusion of the left anterior descending
coronary artery (LAD). SEE = standard error of es-
timate of regression line. All uptake and flow values
in this and other figures are expressed as a percent of
nonischemic values (as in references I, 17 and 34).
• = endocardium, • = epicardium.
IIICROSPHERES OCCLUSION FLOW RATIO
also a close correlation between iodine-125 TPDA uptake
and myocardial flow in animal s undergoing 20 minutes of
coronary occlusion and I hour of reperfusion. This was
especially true for data points corresponding to microsphere
flow values lower than 50% of nonischcmic flow. As in the
case of the 3 hour occlusions (see earlier) , TPDA consist-
ently underestimated (slightly) the severity of regional blood
flow reduction ; this suggests that TPDA is not perfectly
bound .
Also, there were almost identical correlation coefficients ,
slopes and y intercepts in the dogs undergoing either 20
minute or 3 hour left anter ior descend ing coronary artery
ligations and reperfusion (compare Fig. 3 and 5). This in-
dicates that in contrast to thallium-201 myocardial activity
where redistribution importantly alters tracer kinetic s (18),
iodinc-125 TPDA myocardial accumulation after extraction
is not changed by 3 hours of occlusion followed by reperfusion.
Discussion
Distribution of iodine-12S TPDA in myocardium and
advantage of double labeling of TPDA. The findings of
this investigation are as follows: I) Iodine-l25 TPDA dis-
tributes in the myocardium in proporti on to regional myo-
cardial blood flow. Furthermore , this tight ly flow-related
iodine- I25 TPDA uptake is coupled with ischemic myo-
card ial blood flow independent of whether the coronary
artery occlusion followed by reperfusion lasts 20 minutes
or 3 hours , a time interval crit ical in interventions such as
pharmacologic thrombolysis. 2) During left anterior de-
scending coronary artery occlu sion and reperfusion , double
labeling of TPDA with iodine-125 and iodine- I3 I makes it
possible to obtain selective serial determinations of myo-
cardia l blood flow in ischemic and reperfu sed myocardi al
regions.
Because radioiodinated TPDA uptake and microsphere
flow are closely correl ated in low flow region s there would
seem to be a role for radioiodinated TPDA and external
imaging in experimental and possibly clinical studies of
acute myocardi al infarct ion. Furthermore , because radioio-
dinated TPDA does not redistribute (that is, there is no tracer
release from the myocardium with reperfu sion) over time,
this comp ound has great potenti al value for studying myo-
cardial blood flow (compare Fig. 3 and 5). This assertion
is made on the basis of lack of intergroup differences in the
data for Group A animals that did or did not undergo coro-
nary artery reperfusion. The documented similarity between
slope s of the two subgroups plotted in Figure 3 and the slope
of Group B animals confirm s the absence of redistribution .
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Figure 4. Group A. Relation between reperfusion iodine-131TPDA
uptake ratio and microsphere reperfusion flow ratio after I hour
of reperfusion after 3 hours of occlusion of the left anterior de-
scending coronary artery (LAD). • = endocardium; • =
epicardium.
MICROSPHERES OCCLUSION FLOW RATIO
Figure 5. Group B. Relation between iodine-125 TPDA uptake
and myocardial flow in 37 samples from six dogs with 20 minutes
of occlusion of the left anteriordescending coronary artery (LAD).
• = endocardium; • = epicardium.
Red istribution of thallium-201 during acute coro nary oc-
clusion has been documented by varyi ng occlusion times
(18) .
It should be apparent from our data that the slopes relating
TPD A uptake ratios to perfusion ratios appear to be different
early after occlu sion as compared with those computed un-
der conditions ofreperfusion (0 .98 versus 0.74; Fig. 3 ver-
sus 41. This would make the double labeling studies pro-
posed somewhat inaccurate . Further studies should clarify
this potential limitation of the dual labeling technique .
Tomographic imaging. Labeling of TPD A with iodine-
123 was recently achieved (21) by the two-step method used
in our study for the preparation of the iodine- 125 and iodine-
131- labeled analogs . Stud ies now in progress are directed
at develop ing a more simple one-step " kit" method for the
rapid preparation of iodine-123 TPD A. lodine-I 23 TPDA
may provide a satisfactory radiotracer for emission com-
puted tomographic studies of patients with acute myocardial
infarction. Although other radioiodinated fatty acids have
been used in studies of patients with acute myocardial in-
farction (5,8) , these investiga tions have not addressed the
issue of detect ion of the acute myocardial infarct within the
first few hours of its acute onset and the issue of measure-
ment of infarct size. Iodine-l 23 TPDA would appear par-
ticul arly suited for assessment of this subgroup of patients.
Our investigation has also suggested that radioiodinated
TPDA may be used to detect and possibly study the acute
evolution of myocardial region s with depressed blood flow
by means of double label ing of TPDA . Such double label ing
of TPDA with iodine- 123 and other convenient radio-
nuclides (such as bromine-77) combined with external com-
puted tomographi c imaging may prov ide an accurate and
practical means of detecting very low regional myocardial
blood flow consistent with acute myocardial infarction and,
perhaps. monitoring the effect of therapies designed to limit
the extent of acute cardiac necrosis . At a time when throm -
bolytic (22 ,23) and surgical (24) techniques are being eval-
uated for their ability to exert a beneficial effect on the
amo unt of left ventricular myocardium that undergoes ne-
crosis during the first few hours of acute coronary throm-
bosis, positron emissio n tomography is the only accurate
noninvasive moda lity ava ilable for assessi ng the effec t of
these proposed interventional therapies (25-27) . Tomo-
graphic imaging with iodine-123 T PDA may allow detection
of acute myocardial infarction early in its course, and the
technique of double label ing may prov ide repeat measure-
ments of myocardial flow patterns occ urring after throm-
bolysis or coro nary revascularization, or both .
Research directions. These experiments demonstrate
an exce llent correla tion between the uptake of iodine-125
TPDA (give n immediately after occlusion) or iodine-131
TPD A (given after reperfusion) and microsphere measure-
ments of myocardial blood flow in myocardial region s with
low regional arterial flow. Our next series of experiments
are being performed to assess the myocardial kinetic s of
radioiodinated TPDA in ischemic and nonischemic region s
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at various times after occlusion and reperfusion. This in-
vestigation will also consider the effect of nutritional status,
levels of arterial fatty acids, intracellular fatty acid concen-
tration and oxidative status of the cell on radioiodinated
TPDA myocardia uptake.
At all myocardial blood flow levels, myocardial cell up-
take of iodine-131 TPDA was lower than myocardial blood
flow (Fig. 4). This phenomenon, as it relates to radioiodi-
nated TPDA, is probably of no consequence in monitoring
the evolution of acute myocardial infarction because one is
interested in comparing regions of very low myocardial
blood flow to zones demonstrating reperfusion, regardless
of the total amount of reperfusion.
Relative myocardial perfusion. Our myocardial sam-
pling techniques and use of relative myocardial uptakes are
nearly identical to those reported by Poe et al. (1) in their
studies of iodine-123 hexadecanoic acid. Furthermore, our
technique is identical to the method of Pohost et al. (17),
who plotted relative uptake of thallium-201 and micro-
sphere-determined myocardial flows in ischemic myocar-
dium as a percent of nonischemic uptake. Furthermore, we
determined in our laboratory that the ratio of relative isch-
emic and nonischemic coronary flow is equal to the ratio
of the absolute ischemic and nonischemic microsphere flow.
Likewise, Higginson et al. (28) reported coronary artery
flows obtained by the reference method as a ratio of ischemic
and nonischemic flow, thereby confirming our impression
that no loss is incurred by reporting microsphere-measured
coronary blood flow as the ratio of the myocardial counts
in the ischemic to the nonischemic regions.
Toxicology of TPDA. Although our data do not show
evidence of hemodynamic effects of radioiodinated TPDA,
a complete toxicologic analysis of radioiodinated TPDA is
necessary before considering any clinical trials. The modest
lowering of systolic blood pressure in our Group B animals
was probably due to more severe ischemia purposely in-
duced by performing occlusion higher in the left anterior
descending coronary artery, but the possibility of adverse
effects of TPDA remains.
Radionuc1ide measurement of infarct size. Radio-
iodinated TPDA is used for detection of acute myocardial
ischemia and infarction and assessment of interventions
designed to reduce infarct size because of the limitations
of other currently available radionuclide techniques. Of the
other available fatty acids, only radiolabeled heptadecanoic
acid shares common properties with radiolabeled TPDA
(29). However, tellurium-123m-9-telluraheptadecanoic acid
requires labelingwith a radiotracerthat is not readilyavailable.
Technetium-vvm-Srr'" -pyrophosphate scintigraphy for
delineation of myocardial infarct size has three important
limitations: 1) images are not optimal until 48 to 72 hours
after the onset of acute myocardial infarction; 2) the radio-
tracer is taken up not only by necrotic cardiac cells but also
by ischemic myocardium (30,31); and 3) pyrophosphate
scintigraphy is not a sensitive technique for detecting sub-
endocardial myocardial necrosis (32).
Thallium-201 scintigraphy is markedly limited for myo-
cardial infarct sizing because of the poor photopeak energy
of thallium-201 (about 80 keY) and the phenomenon of
tracer redistribution which is independent of myocardial
blood flow (18). Beller (33) recently reviewed the potential
use of thallium scintigraphy to assess coronary thrombo-
lysis. Thallium-201 redistribution at rest complicates eval-
uation of thrombolysis.
Finally, positron emission tomography can delineate
myocardial blood flow and fatty acid metabolism during
acute myocardial infarction and, thus, be used for infarct
sizing (25-27), but this technique requires expensive in-
strumentation and complex radiopharmaceutical agents that
need an on-site cyclotron. The latter two conditions make
positron emission tomography prohibitive for most hospitals.
In summary, the present investigation has shown that: 1)
radioiodinated TPDA delineates endocardial and epicardial
myocardial zones with low blood flow in experimental coro-
nary occlusions lasting 20 to 180 minutes and followed by
reperfusion, and 2) dual labeling of TPDA offers a poten-
tially attractive means of assessing interventional therapies,
such as thrombolysis or coronary artery revascularization,
or both, which are aimed at infarct size reduction.
We thank Margot Matthews and Armand Powers, who provided excellent
technical support and H. William Strauss, MD, who discussed this manu-
script with us and offered useful comments.
References
I. Poe NO, Robinson GO, Graham SL, MacDonald NS. Experimental
basis for myocardial imaging with 1231-labeled hexadecanoic acid. J
Nucl Med 1976;17:1077-82.
2. Machulla H-J, Stocklin G, Kupfemagel Ch, et al. Comparative eval-
uation of fatty acids labeled with C-II, CI-34m, Br-77 and 1-123 for
metabolic studies of the myocardium. J Nucl Med 1978;19:298-302.
3. Freundlieb C, Hock A, Vyska K, Feinendegen LF, Machulla H-J,
Stocklin G. Myocardial imaging and metabolic studies with (17- l23 I)
iodoheptadecanoic acid. J Nucl Med 1980;21:1043-50.
4. Van der Wall EE, Heidendal GAK, der Hollander W, Westera G,
Roos JP. 1-123 labeled hexadecanoic acid in comparison with thallium-
201 for myocardial imaging in coronary heart disease. Eur J Nucl
Med 1980;5:401-9.
5. Van der Wall EE, der Hollander W, Heidendal GAK, Westera G,
Majid PA, Roos JP. Dynamic myocardial scintigraphy with 1231-la-
beled free fatty acids in patients with myocardial infarction. Eur J
Nucl Med 1981;6:383-9.
6. Van der Wall EE, Heidendal GAK, der Hollander W, Westera G,
Ross JP. Metabolic myocardial imaging with 1231-labeled heptadeca-
noic acids in patients with angina pectoris. Eur J Nucl Med 1981 ;6:391-6.
7. Hock A, Freundlieb C, Vyska K, Losse B, Erbel R, Feinendegen LE.
Myocardial imaging and metabolic studies of (17_1231) iodoheptade-
canoic acid in patients with idiopathic congestive cardiomyopathy. J
Nucl Med 1983;24:22-8.
JACC Yo . 4, No.
July 1984 8Q-7
BIANCOETAL.
TPDAIN ISCHEMIA
87
8. Roexler H, HessT, WeissM, et al. Tomoscintigraphic assessment of
myocardial metabolic heterogeneity. 1 Nucl Med 1983;24:285-96.
9. Goodman MM, Knapp FF Jr. Callahan AP, FerrenLA. A new well-
retained myocardial imaging agent: radioiodinated 15-(p-iodophenyl)-
6-teJlurapentadecanoic acid. 1 Nucl Med 1982;23:904-8.
10. Goodman MM, Knapp FF lr. Synthesis of 15-(p-iodophenyl)-6-tel-
lurapentadecanoic acid:a new myocardial imaging agent.1Org Chern
1982;47:3004-6.
II. Knapp FF Jr, Goodman MM, Callahan AP. Radioiodination of 15-
(p-iodophenyl)-6-tellurapentadecanoic acidby triazene decomposition
witt, radioiodide. 1 Lab Comp Radiophann 1982;19:1323-7.
12. ChI.< A, Murdock RH, CobbFR. Relation between regional distribution
ofthallium-201 andmyocardial bloodflow innormal,acutely ischemic
and infarcted myocardium. Am 1 CardioI1982;50:1141-4.
13. Heyman MA, Payne BD, Hoffman IE, Rudolph AM. Blood flow
measurements with radionuclide-labeled particles. Prog Cardiovasc
Dis 1977;20:55-79.
14. Murdock RH, Cobb FR. Effectsof infarcted myocardium on regional
blood flow measurements to ischemic regions in canine heart. Circ
Res 1980;47:701-9.
15. Zar IH. Comparing simple linear regression equations . In: Biosta-
tistical Analysis. Englewood Cliffs, Nl: Prentice-Hall , 1974:228-33.
16. Vokonas PS, Malsky PM, Paul Sl, Robbins SL, Hood WB lr. Ra-
dioautographic studies in experimental myocardial infarction: profiles
of ischemic blood flow and quantification of infarctsize in relation to
magnitude of ischemic zone. Am 1 Cardiol 1978;42:67-76.
17. Pohost G, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller
GA. Differentiation of transiently ischemic from infarcted myocar-
diu:nby serial imaging aftera singledoseof thallium-20 I. Circulation
19':' 7;55:294-302.
18. Pohost GM, Okada RD, O'Keefe DD, et al. Thallium redistribution
in dogs with severe coronary stenosis of fixed caliber. Circ Res
I% 1;48:439-46.
19. Strauss HW, Harrison K, Langan lK , Lebowitz E, Pitt B. Thallium-
20I for myocardial imaging: relation of thallium-20 I to regional myo-
cardial perfusion. Circulation 1975;51 :641-5.
20. WeichHF, StraussHW, Pitt B. The extraction of thallium-201 by the
myocardium. Circulation 1977;56:188-91.
21. Goodman MM, Callahan AP, Knapp FF Jr, et al. New myocardial
imaging agents-preparation of 15-(p-[123Ijiodophenyl)-6-tellurahepta-
decanoic acid from Na[123I] by a triazene decomposition reaction. In:
International Symposium on the Developing Role of Short-Lived
Radionuclides in NuclearMedical Practice . Washington, D.C.: U.S.
Department of Energy, 1982.
22. Rentrop KP, Blanke H, Karsch KR, et al. Acutemyocardial infarction:
intracoronary application of nitroglycerin and steptokinase. Clin Car-
diol 1979;2:354-60.
23. Karsch KR, Hofmann M, RentropKP, BlankeH, SchaperW. Throm-
bolysisinacuteexperimental myocardial infarction . 1AmCoilCardiol
1983;1 :427-35.
24. DeWood MA, Spores1, BergR Jr. et al. Acutemyocardial infarction:
a decadeof experience with surgical reperfusion in 70I patients. Cir-
culation 1983;68(suppl 1I):II-8-16.
25. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an
indicatorof myocardial blood flow . Circulation 1981 ;63:1259-72.
26. Weiss ES, Ahmed SA, Welch Ml, Williamson lR, Ter-Pogossian
MM, SobelBE. Quantification of infarction incrosssectionsof canine
myocardium in vivowithpositronemissiontransaxial tomography and
II-C-palmitate. Circulation 1977;55:66-73.
27. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and dif-
ferentiation of restingmyocardial ischemiaand infarction in man with
positron computed tomography, IsF-labeled fluorodeoxyglucose and
N-13 ammonia. Circulation 1983;67:766-78.
28. Higginson LA, Beanlands DS, Nair RC, TempleV, Sheldrick K. The
timecourseandcharacterization of myocardial hemorrhage aftercoro-
nary reperfusion in the anesthetized dog. Circulation 1983;67:1024-31.
29. Okada RD, KnappFF, Elmaleh DR, YasudaT, BoucherCA, Strauss
HW. Tellurium-123m-labeled-9-telluraheptadecanoic acid: a possible
cardiac imaging agent. Circulation 1982;65:305-10.
30. Kronenberg MW, EttingerUR, Wilson GA, SchenkEA, Cohen1. A
comparison of radiotracer and biochemical methods for the quanti-
tationof experimental myocardial infarctweight: in vitrorelationships .
1 Nucl Med 1979;20:224-31.
31. Bianco lA , Kemper AI, Taylor A, Lazewatsky 1, Tow DE, Khuri
SF. Technetium-99m-Sn2 + -pyrophosphate in ischemic and infarcted
myocardium in early stagesof caninecoronaryocclusion: histochem-
ical and tissue countingcomparisons . 1 Nucl Med 1983;24:485-91.
32. Massie BM, Botvinick EH, Weiner lA , Chatterjee K, Pannley WW.
Myocardial scintigraphy with technetium-99m stannous pyrophos-
phate: an insensitive test for nontransmural myocardial infarction . Am
1 Cardiol 1979;43:186-92.
33. BellerGA. Myocardial imaging with thallium-201 for assessment of
regional myocardial perfusion and viability after intracoronary throm-
bolytic therapy. Circulation 1983;68(suppl 1):1-70-6.
34. DiCola VC, Downing S, Donabedian RK, Zaret BL. Pathophysio-
logical correlates of thallium-201 myocardial uptake in experimental
infarction. Cardiovasc Res 1977;11:141-6.
